Literature DB >> 26164792

Non-IgE mediated mast cell activation.

Yingxin Yu1, Bart R Blokhuis1, Johan Garssen1, Frank A Redegeld2.   

Abstract

Mast cells are crucial effector cells in allergic reactions, where IgE is the best known mechanism to trigger their degranulation and release of a vast array of allergic mediators. However, IgE is not the only component to stimulate these cells to degranulate, while mast cell activation can also result in differential release of mediators. There is a plethora of stimuli, such as IgG, complement components, TLR ligands, neuropeptides, cytokines, chemokines and other inflammatory products, that can directly trigger mast cell degranulation, cause selective release of mediators, and stimulate proliferation, differentiation and/or migration. Moreover, some of these stimuli have a synergic effect on the IgE-mediated mast cell activation. Because of the ability to respond to a large repertoire of stimuli, mast cells may act as a versatile cell in various physiological and pathological conditions. In this review, we discuss current knowledge on non-IgE stimuli for (human) mast cells.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26164792     DOI: 10.1016/j.ejphar.2015.07.017

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  36 in total

1.  Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation.

Authors:  Yan-Ni Mi; Na-Na Ping; Yong-Xiao Cao
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

2.  Mesenchymal Stem Cell-Derived Exosomes Attenuate TLR7-Mediated Mast Cell Activation.

Authors:  Kyung-Ah Cho; Je-Eun Cha; Jungwoo Kim; Yu-Hee Kim; Kyung-Ha Ryu; So-Youn Woo
Journal:  Tissue Eng Regen Med       Date:  2021-11-18       Impact factor: 4.169

Review 3.  Dural Immune Cells, CGRP, and Migraine.

Authors:  Louis K Balcziak; Andrew F Russo
Journal:  Front Neurol       Date:  2022-03-31       Impact factor: 4.086

4.  Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria.

Authors:  Ji-Hye Kim; Hyung-Young Lee; Ga-Young Ban; Yoo-Seob Shin; Hae-Sim Park; Young-Min Ye
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

5.  No Role for Mast Cells in Obesity-Related Metabolic Dysregulation.

Authors:  Jindřich Chmelař; Antonios Chatzigeorgiou; Kyoung-Jin Chung; Marta Prucnal; David Voehringer; Axel Roers; Triantafyllos Chavakis
Journal:  Front Immunol       Date:  2016-11-24       Impact factor: 7.561

Review 6.  Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer.

Authors:  Angélica Aponte-López; Ezequiel M Fuentes-Pananá; Daniel Cortes-Muñoz; Samira Muñoz-Cruz
Journal:  J Immunol Res       Date:  2018-02-05       Impact factor: 4.818

7.  Mast cells are important regulator of acupoint sensitization via the secretion of tryptase, 5-hydroxytryptamine, and histamine.

Authors:  Ning Ding; Jing Jiang; Pingping Qin; Qiaoxia Wang; Jiatong Hu; Zhigang Li
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

8.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12

Review 9.  Controlling Mast Cell Activation and Homeostasis: Work Influenced by Bill Paul That Continues Today.

Authors:  Heather L Caslin; Kasalina N Kiwanuka; Tamara T Haque; Marcela T Taruselli; H Patrick MacKnight; Anuya Paranjape; John J Ryan
Journal:  Front Immunol       Date:  2018-04-26       Impact factor: 7.561

10.  P2X7R in Mast Cells is a Potential Target for Salicylic Acid and Aspirin in Treatment of Inflammatory Pain.

Authors:  Yucui Jiang; Fan Ye; Ying Du; Yingxin Zong; Zongxiang Tang
Journal:  J Inflamm Res       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.